Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk

被引:0
作者
Michael S. Shawky
Carmela Ricciardelli
Megan Lord
John Whitelock
Vito Ferro
Kara Britt
Erik W. Thompson
机构
[1] University of Alexandria,Department of Head and Neck and Endocrine Surgery, Faculty of Medicine
[2] Waikato Hospital,Department of Surgery
[3] University of Adelaide,School of Medicine, Robinson Research Institute
[4] University of New South Wales,Graduate School of Biomedical Engineering
[5] University of Queensland,School of Chemistry and Molecular Biosciences
[6] Peter MacCallum Cancer Centre,The Sir Peter MacCallum Department of Oncology
[7] University of Melbourne,Institute of Health and Biomedical Innovation and School of Biomedical Science
[8] Queensland University of Technology,Department of Surgery, St Vincent’s Hospital
[9] University of Melbourne,undefined
来源
Journal of Mammary Gland Biology and Neoplasia | 2015年 / 20卷
关键词
Breast cancer; Mammographic density; Proteoglycans; Extracellular matrix; Syndecan; Versican; Perlecan; Glypican; Heparanase;
D O I
暂无
中图分类号
学科分类号
摘要
Although increased mammographic density (MD) has been well established as a marker for increased breast cancer (BC) risk, its pathobiology is far from understood. Altered proteoglycan (PG) composition may underpin the physical properties of MD, and may contribute to the associated increase in BC risk. Numerous studies have investigated PGs, which are a major stromal matrix component, in relation to MD and BC and reported results that are sometimes discordant. Our review summarises these results and highlights discrepancies between PG associations with BC and MD, thus serving as a guide for identifying PGs that warrant further research towards developing chemo-preventive or therapeutic agents targeting pre-invasive or invasive breast lesions, respectively.
引用
收藏
页码:121 / 131
页数:10
相关论文
共 629 条
[41]  
Lakins JN(2008)Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs Int J Cancer 123 2473-15
[42]  
Egeblad M(2012)Significance of stromal decorin expression during the progression of breast cancer Oncol Rep 28 2003-9
[43]  
Erler JT(2011)Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas BMC Cancer 11 314-46
[44]  
Butcher DT(2001)Mammographic density changes during the menstrual cycle Cancer Epidemiol Biomarkers Prev 10 141-44
[45]  
Alliston T(2006)Mammographic breast density, dense area, and breast area differences by phase in the menstrual cycle Cancer Epidemiol Biomarkers Prev 15 2303-97
[46]  
Weaver VM(2012)Decorin: a guardian from the matrix Am J Pathol 181 380-614
[47]  
Lyons TR(2004)Regulation, regulatory activities, and function of biglycan Crit Rev Eukaryot Gene Expr 14 301-23
[48]  
O’Brien J(2014)Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy Mol Cell Ther 2 14-50
[49]  
Borges V(2013)Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatment Breast Cancer 5 43-30
[50]  
Conklin MW(2010)Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis BMC Cancer 10 665-55